A relatively new method of heart transplantation, which allows for the use of hearts donated after circulatory death could expand the pool of available donor hearts by a projected 30%. Here's what's happening.
Presented at ESC HFA 2023, results of PARAGLIDE-HF detail the effects of sacubitril/valsartan on NT-proBNP and multiple clinical outcomes, relative to valsartan alone, in patients with HFmrEF or HFpEF.
The post-implantation electrocardiogram from the first pig heart xenotransplantation resembled neither a pig nor a human ECG, with unknown implications for future heart xenograft recipients.
This observational follow-up study of patients from the MOMENTUM 3 randomized trial compares outcomes and overall survival in individuals who received a fully m